Shares of a leading provider of molecular diagnostic assays, products, and services Biocept Inc. (NASDAQ: BIOC) were rising 3.83% to trade at $5.15 in premarket trading at the time of the last check. In Tuesday’s session, Biocept stock closed at $4.96, down -2.17%. In contrast to the 0.48 million shares of average daily volume, BIOC stock volume remained at 0.23 million shares. News of the supply COVID-19 testing is driving BIOC stock up.
News in brief:
In addition to developing and commercializing molecular diagnostic assays, Biocept also provides physicians with clinically actionable information for diagnosing and treating patients diagnosed with a variety of cancers. Furthermore, BIOC has developed a cerebrospinal fluid assay that detects cancer cells that have spread to the central nervous system, the CNSide cerebrospinal fluid assay.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Read More
More than 2.1 million students and more than 116 California community colleges will be able to take COVID-19 tests, thanks to a partnership between Biocept and the Foundation for California Community Colleges announced today.
- Community colleges can now purchase BIOC’s PCR-based COVID-19 test for students, faculty, and staff through the Foundation’s CollegeBuys program.
- Test results will be accessible to the campus population to help protect their safety.
- It will reduce the spread of the virus on campus as well as in surrounding communities.
- The move will also help colleges return to the traditional setting from remote learning adopted as a result of the COVID-19 pandemic.
How will it work?
By combining PCR and COVID-19 testing, Biocept (BIOC) offers colleges CLIA-certified, and CAP-accredited San Diego laboratory services. Typically, results are available within 48 hours of BIOC receiving the sample, reducing lengthy turnaround times which will be administered by a health care provider using a nasal or oral swab.
